114 related articles for article (PubMed ID: 17103487)
21. Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Herold KC; Gitelman S; Greenbaum C; Puck J; Hagopian W; Gottlieb P; Sayre P; Bianchine P; Wong E; Seyfert-Margolis V; Bourcier K; Bluestone JA;
Clin Immunol; 2009 Aug; 132(2):166-73. PubMed ID: 19443276
[TBL] [Abstract][Full Text] [Related]
22. Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.
Yoo HJ; Hartling SG; Binder C
Korean J Intern Med; 1987 Jul; 2(2):196-200. PubMed ID: 3154831
[TBL] [Abstract][Full Text] [Related]
23. β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes.
Gitelman SE; Evans-Molina C; Guolo A; Mari A; Ferrannini E
Diabetes; 2023 Sep; 72(9):1289-1296. PubMed ID: 37368990
[TBL] [Abstract][Full Text] [Related]
24. Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data.
Brown RJ; Rother KI
Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):14-22. PubMed ID: 18221429
[No Abstract] [Full Text] [Related]
25. Recommendations for the definition of clinical responder in insulin preservation studies.
Beam CA; Gitelman SE; Palmer JP;
Diabetes; 2014 Sep; 63(9):3120-7. PubMed ID: 24722251
[TBL] [Abstract][Full Text] [Related]
26. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Greenbaum CJ; Beam CA; Boulware D; Gitelman SE; Gottlieb PA; Herold KC; Lachin JM; McGee P; Palmer JP; Pescovitz MD; Krause-Steinrauf H; Skyler JS; Sosenko JM;
Diabetes; 2012 Aug; 61(8):2066-73. PubMed ID: 22688329
[TBL] [Abstract][Full Text] [Related]
27. Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes.
Dalle S
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928130
[TBL] [Abstract][Full Text] [Related]
28. Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes.
Lundkvist P; Grönberg A; Carlsson PO; Ludvigsson J; Espes D
BMJ Open Diabetes Res Care; 2024 Feb; 12(1):. PubMed ID: 38413173
[TBL] [Abstract][Full Text] [Related]
29. Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Latres E; Greenbaum CJ; Oyaski ML; Dayan CM; Colhoun HM; Lachin JM; Skyler JS; Rickels MR; Ahmed ST; Dutta S; Herold KC; Marinac M
Diabetes; 2024 Jun; 73(6):823-833. PubMed ID: 38349844
[TBL] [Abstract][Full Text] [Related]
30. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?
Pinger CW; Entwistle KE; Bell TM; Liu Y; Spence DM
Mol Biosyst; 2017 Jul; 13(8):1432-1437. PubMed ID: 28685788
[TBL] [Abstract][Full Text] [Related]
31. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.
Sims EK; Bundy BN; Stier K; Serti E; Lim N; Long SA; Geyer SM; Moran A; Greenbaum CJ; Evans-Molina C; Herold KC;
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658358
[TBL] [Abstract][Full Text] [Related]
32. Adipose Tissue-Derived Stromal/Stem Cells Transplantation with Cholecalciferol Supplementation in Recent-Onset Type 1 Diabetes Patients: Twelve Months Follow-Up.
Dantas JR; Araujo DB; Silva KR; Souto DL; Pereira MFC; Raggio LR; Claudio-da Silva C; Couri CE; Maiolino A; Rebellato CLK; Daga DR; Senegaglia AC; Brofman PRS; Baptista LS; Oliveira JEP; Zajdenverg L; Rodacki M
Horm Metab Res; 2023 Aug; 55(8):536-545. PubMed ID: 37192655
[TBL] [Abstract][Full Text] [Related]
33. Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function.
Fanaropoulou NM; Tsatsani GC; Koufakis T; Kotsa K
Expert Rev Clin Immunol; 2024 Feb; 20(2):185-196. PubMed ID: 37937833
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial.
Marcovecchio ML; Wicker LS; Dunger DB; Dutton SJ; Kopijasz S; Scudder C; Todd JA; Johnson PRV
Wellcome Open Res; 2020; 5():49. PubMed ID: 32399500
[TBL] [Abstract][Full Text] [Related]
35. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.
Herold KC; Gitelman SE; Gottlieb PA; Knecht LA; Raymond R; Ramos EL
Diabetes Care; 2023 Oct; 46(10):1848-1856. PubMed ID: 37607392
[TBL] [Abstract][Full Text] [Related]
36. Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?
Bresson D; von Herrath M
Autoimmun Rev; 2007 Apr; 6(5):315-22. PubMed ID: 17412305
[TBL] [Abstract][Full Text] [Related]
37. The future is on the way: β cell function preservation for type 1 diabetes.
Yang J; Wei R
Med; 2024 Jan; 5(1):4-6. PubMed ID: 38218175
[TBL] [Abstract][Full Text] [Related]
38. A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes.
Ylescupidez A; Bahnson HT; O'Rourke C; Lord S; Speake C; Greenbaum CJ
Nat Commun; 2023 Nov; 14(1):7214. PubMed ID: 37940642
[TBL] [Abstract][Full Text] [Related]
39. Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial.
Raz I; Ziegler AG; Linn T; Schernthaner G; Bonnici F; Distiller LA; Giordano C; Giorgino F; de Vries L; Mauricio D; Procházka V; Wainstein J; Elias D; Avron A; Tamir M; Eren R; Peled D; Dagan S; Cohen IR; Pozzilli P;
Diabetes Care; 2014; 37(5):1392-400. PubMed ID: 24757230
[TBL] [Abstract][Full Text] [Related]
40. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Wherrett DK; Bundy B; Becker DJ; DiMeglio LA; Gitelman SE; Goland R; Gottlieb PA; Greenbaum CJ; Herold KC; Marks JB; Monzavi R; Moran A; Orban T; Palmer JP; Raskin P; Rodriguez H; Schatz D; Wilson DM; Krischer JP; Skyler JS;
Lancet; 2011 Jul; 378(9788):319-27. PubMed ID: 21714999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
